Please assess the completion status of the following clinical trial:

Trial Title: Randomized Double-blind Trial of Midazolam and Loxapine in Agitated Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Severely agitated patients (Richard Scale over or equal to 5) between 18 and 65 years old~Exclusion Criteria:~Hypoglycemia hypoxemia patients with known dementia blood pressure \<90 mmHg known cocaine or amphetamine intoxication pregnancy respiratory or liver insufficiency myasthenia sedation before arrival to hospital

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- loxapine (Type: ACTIVE_COMPARATOR): agitated patients were randomly assigned either to loxapine, either to midazolam group
- midazolam (Type: ACTIVE_COMPARATOR): midazolam is compared to loxapine in terms of efficacy and tolerance

Based on this trial design, predict the completion outcome and termination type (if applicable).